Pneumonia in Children: Pharmacogenetic Aspect in the Appearence of the Severe Forms and Complications of the Disease (Literature Review and Clinical Case Presentation)

Journal Title: Lviv Clinical Bulletin - Year 2017, Vol 1, Issue 17

Abstract

Introduction. Respiratory system diseases were and continue to be a topical problem of the medicine overall and pediatrics in particular. Pneumonia is the most serious disease that kills children under 5 years old globally, taking about 1 million lives every year. Purpose of the study. To analyze the domestic and foreign literary sources of information dedicated to the role of pharmacogenetics in appearances of the severe forms and complications of pneumonia in children and also to describe a clinical case. Materials and research methods. Content­analysis, methods of systemic and comparative analysis, biblio semantic method of the actual scientific researches study about the role of pharmacogenetics in appearence of severe forms and pneumonia complications in children, analysis of a case of the disease of a particular patient who was under our observation. Source searching was done with the scientometric databases of medical information: PubMed­NC­BI, Medline, CochraneLibrary, EMBASE, ResearchGate using keywords: pneumonia, children, pharmacogenetics, xenobiotic biotransformation genes. In all, 41 sources in English, Russian and Ukrainian languages were analyzed. Results of the analysis. Pneumonia is an acute infectious inflammatory disease of the lung parenchyma, characterized by the infiltrative changes in lung tissue and respiratory failure. A lot of microorganisms can be a reason for pneumonia occurrence. Among the most common bacteria pathogens are: Streptococcus pneumoniae, Haemophilus influenzae type B, and among viruses it’s Human respiratory syncytial virus. Despite the timely diagnosis and an appropriate drug therapy the number of severe forms and complications of pneumonia is not being reduced. A lot of scientific studies of this topic during the last years are aimed at genetics exploration. Particularly, the area of pharmacogenetics is interesting and perspective part of it. About 50 % of adverse responses to drugs are caused by the genetic factors. Study of pharmacogenetic impact can serve as a basis for a creation of the individualized approach to the choice of treatment tactics and to the dosage regime. Genetic polymorphisms of xenobiotic metabolism determines the division of people into groups that differ in their ability to metabolize drugs from insufficient to ultrafast metabolisers. Genetic polymorphisms of xenobiotic metabolism can be the reason for occurrence of severe forms and complications of various diseases, including pneumonia in children. These genes include: glutathione transferases (GSTM), O­ and N­acetyltransferases (OAT, NAT1, NAT2) and others. Among the proteins which affect the speed of excretion of the pharmacological agents the special place belongs to P­glycoprotein, encoded by the gene MDR1. The research results of different authors showed that genetic polymorphism of MDR1 can be an important factor that determines the predisposition to various diseases and resistance to treatment. Conclusions. The researches of genes involved in the distribution, biotransformation and excretion of toxic products of decay of drugs, is a promising and important component of the pathogenesis and, accordingly, the diagnosis and treatment of pneumonia in children.

Authors and Affiliations

С. Л. Няньковський, Р. Н. Фуртак, М. С. Яцула, О. І. Шпичка

Keywords

Related Articles

Structural and Functional Features of the Heart and Blood Vessels in Hypertensive Patients with Different Body Mass

Introduction. Pathological effects of obesity are realized primarily through arterial hypertension, hypercholesterolemia, glucose intolerance, the prevalence of which is increasing among people with excessive body weight...

Пневмонии у детей: фармакогенетический аспект в возникновении тяжелых форм и осложнений заболевания (обзор литературы и описание клинического случая)

Введение. Пневмония остается серьезным заболеванием, которое убивает детей в возрасте до пяти лет на глобальном уровне, забирая около миллиона детских жизней ежегодно. В последние годы, по статистике Минздрава Украины и...

Уміст дигідротестостерону в крові у жінок у постменопаузному періоді залежно від коморбідної патолоґії: цукровий діабет 2­-го типу та артеріальна гіпертензія

Вступ. Сьогодні доведена активність стероїдоґенної функції яєчників у жінок у постменопаузі. Відомо, що однією з найбільш біолоґічноактивних форм тестостерону в чоловіків і жінок, яка утворюється з тестостерону безпосере...

Monthly Dynamics of Cases of Laryngotracheitis and Recurrent Laryngotracheitis in Children and their Relation to Respiratory Viruses

Introduction. One of the most common syndromes in pediatrics is stenotic laryngotracheitis (SLT), in which genesis has a leading role in viruses, and is also characterized by certain seasonal rhythms. In contrast to SLT,...

Characteristic of Calcium and Phosphorus Homeostasis and Bone Mineral Density in Children from Ecologically Polluted Regions Before and After Treatmen

Introduction. One of the decisive mechanisms of the influence of xenobiotics on a human organism is the disturbance of calcium-phosphorous homeostasis and oxidative metabolism of cells due to the changes in the intracell...

Download PDF file
  • EP ID EP254296
  • DOI 10.25040/lkv2017.01.053
  • Views 170
  • Downloads 0

How To Cite

С. Л. Няньковський, Р. Н. Фуртак, М. С. Яцула, О. І. Шпичка (2017). Pneumonia in Children: Pharmacogenetic Aspect in the Appearence of the Severe Forms and Complications of the Disease (Literature Review and Clinical Case Presentation). Lviv Clinical Bulletin, 1(17), 53-59. https://www.europub.co.uk/articles/-A-254296